Trial | Journal | Surgical procedure | Number of patients | Statin | Statin regimen | Control | Patients naïve to statin therapy (%) | Outcomes for meta-analysis | Risk of bias |
---|---|---|---|---|---|---|---|---|---|
Cardiac surgery | |||||||||
Almansob 2012 | Arterioscler Thromb Vasc Biol | Non-coronary cardiac surgery | 132 | Simvastatin 20 mg | 5–7 days pre-op and post-op day 2 | No treatment | nr | MI, S, M | High |
Aydin 2015 | Anatol J Cardiol | On-pump CABG | 60 | Atorvastatin | 7Â h post-op and 30Â days post-op | No treatment | 100 | MI, M | High |
Baran 2011 | Stem Cell Rev and Rep | On-pump CABG | 60 | Atorvastatin 40Â mg | 14Â days pre-op and post-op (no day 0) | Placebo | 100 | AKI, MI, S, M, RRT | High |
Berkan 2008 | Thorac Cardiov Surg | On-pump CABG | 46 | Fluvastatin 80Â mg | 3Â weeks pre-op | Placebo | 100 | MI | High |
Billings 2016 | JAMA | On-/Off-pump cardiac surgery | 615 | Atorvastatin 40 mg | Bid day 1, qd day 0, and qd post-op° | Placebo | 32 | AKI, MI, S, M, RRT | Low |
Carrascal 2016 | Journal of Arrhythmia | Valvular surgery | 90 | Atorvastatin 40Â mg | 7Â days pre-op and 7Â days post-op | No treatment | 100 | AKI, MI, S, M, RRT | High |
Castaño 2015 | J Cardiovasc Surg | On-pump CABG | 30 | Pravastatin 40 or 80 mg | 2 h pre-op | Placebo | 0 | AKI, MI, S, M, RRT | Low |
Chello 2006 | Crit Care Med | On-pump CABG | 40 | Atorvastatin 20Â mg | 3Â weeks pre-op | Placebo | 100 | AKI, MI, S, M | Unclear |
Christenson 1998 | Eur J Cardiothorac Surg | On-pump CABG | 77 | Simvastatin 20Â mg | 4Â weeks pre-op | No treatment | nr | AKI, MI, M | High |
Dehghani 2014 | J Cardiovasc Pharmacol Ther | Valvular surgery | 58 | Atorvastatin 40Â mg | 3Â days pre-op and 5Â days post-op | Placebo | 100 | MI, S, M | High |
Hua 2017 | Biomed Res Int | Valvular surgery | 130 | Simvastatin 20 mg | 5–7 days pre-op and 7 days post-op (no days 0–1). | Placebo | 100 | M | High |
Ji 2009 | Circ J | Off-pump CABG | 140 | Atorvastatin 20Â mg | 7Â days pre-op | Placebo | 100 | MI, S, M | High |
Mannacio 2008 | J Thorac Cardiovasc Surg | On-pump CABG | 200 | Rosuvastatin 20Â mg | 7Â days pre-op | Placebo | 100 | AKI, MI, S, M | High |
Mansour 2016 | Int J Adv Biomed | Cardiac surgery | 50 | Atorvastatin 40Â mg | 7Â days pre-op and post-op | No treatment | 100 | MI, S, M | High |
Nakamura 2006 | Cytokine | On-/Off-pump CABG | 31 | Atorvastatin 10Â mg | Unclear | No treatment | 32 | M | Unclear |
Park 2016 | Intensive Care Med | Valvular surgery | 200 | Atorvastatin 40 mg | Bid day − 1 and qd days 0–1–2 | Placebo | 100 | AKI, MI, S, M, RRT | Low |
Patti 2006 | Circulation | On-pump cardiac surgery | 200 | Atorvastatin 40Â mg | 7Â days pre-op and post-op until discharge (no day 0) | Placebo | 100 | MI, M | High |
Prowle 2012 | Nephrology | On-pump cardiac surgery | 100 | Atorvastatin 40 mg | Days 0–1–2–3 | Placebo | 30 | AKI, M, RRT | Low |
Song 2008 | Am Heart J | Off-pump CABG | 124 | Atorvastatin 20Â mg | 3Â days pre-op and continued for 30Â days post-op | No treatment | 100 | MI, S | High |
Spadaccio 2010 | J Cardiovasc Pharmacol | On-pump CABG | 50 | Atorvastatin 20Â mg | 3Â weeks pre-op | Placebo | 100 | AKI, MI, S, M | Unclear |
Sun 2011 | Int Heart J | On-pump CABG | 100 | Atorvastatin 20Â mg | 7Â days pre-op | Placebo | 100 | MI | High |
Tamayo 2009 | J Thorac Cardiovasc Surg | On-pump CABG | 44 | Simvastatin 20Â mg | 3Â weeks pre-op | No treatment | 100 | M | High |
Vukovic 2010 | Perfusion | On-pump CABG | 57 | Atorvastatin 20Â mg | 3Â weeks pre-op | Placebo | 100 | MI, M | High |
Youn 2011 | Korean J Thorac Cardiovasc Surg | Off-pump CABG | 142 | Rosuvastatin 40Â mg | Bid day 1, qd day 0 | No treatment | 45 | MI, M | High |
Zheng 2016 | N Engl J Med | On–/Off-pump CABG/AVR/CABG + AVR | 1922 | Rosuvastatin 20 mg | 1–8 days pre-op and 5 days post-op | Placebo | 66 | AKI, MI, S, M, RRT | Low |
Non-cardiac surgery | |||||||||
Amar 2015 | J Thorac Cardiovasc Surg | Pulmonary resection | 88 | Atorvastatin 40Â mg | 7Â days pre-op and 7Â days post-op | Placebo | 100 | MI, M | High |
Bass 2018 | HSSJ | Hip fracture and total hip/knee replacement surgery | 20 | Atorvastatin 40Â mg | 4Â days pre-op and 45Â days post-op | Placebo | 100 | AKI, MI, S, M | High |
Berwanger 2017 | Am Heart J | Non-cardiac surgery in high-risk patientsa | 642 | Atorvastatin 80Â mg | 1Â day pre-op and seven days post-op | Placebo | 100 | AKI, MI, S, M | High |
Durazzo 2004 | J Vasc Surg | Aortic, femoropopliteal, and carotid vascular surgery | 100 | Atorvastatin 20Â mg | At least 14Â days pre-op and up to 4Â weeks post-op | Placebo | 100 | MI, S, M | Low |
Neilipovitz 2012 | Can J Anaesth | Non-cardiac surgery in high-risk patientsb | 76 | Atorvastatin 80Â mg | 7Â days pre-op and 7Â days post-op or day 0 and 7Â days post-op | Placebo | 100 | MI, S, M | High |
Parepa 2017 | Farmacia | Elective non-cardiac, non- vascular surgery without known cardiac disease | 1380 | Rosuvastatin 10Â mg | 10Â days pre-op and 20Â days post-op | Placebo | 100 | MI, M | High |
Shyamsundar 2014 | Annals of Surgery | Esophagectomy | 31 | Simvastatin 80Â mg | 4Â days pre-op and 7Â days post-op | Placebo | 100 | AKI, MI, S, M | Unclear |
Singh 2016 | J Am Coll Surg | Colorectal resection or reversal of Hartmann’s procedure surgery | 132 | Simvastatin 40 mg | 3–7 days pre-op and 14 days post-op | Placebo | 100 | M | Low |
Xia 2014 | Cardiology | Urgent abdominal surgeryc in patients with stable CAD | 500 | Atorvastatin 80Â mg | 2Â h before surgery | Placebo | 0 | MI, M | Low |
Xia 2015 | Cardiology | Urgent abdominal surgeryc in patients with stable CAD | 550 | Rosuvastatin 20Â mg | 2Â h before surgery | Placebo | 0 | MI, S, M | Unclear |